NCT07429487 (WATCH AND ACT) is a NA clinical trial of APA program in Breast Cancer, sponsored by Centre Antoine Lacassagne.

Who is sponsoring NCT07429487?

NCT07429487 is sponsored by Centre Antoine Lacassagne.

What drugs are being tested in NCT07429487?

Interventions in NCT07429487: APA program.

What condition does NCT07429487 study?

NCT07429487 studies Breast Cancer, Colorectal Cancer, Ovarian Adenocarcinoma, Pancreatic Cancer, Gastric Adenocarcinoma.

Is NCT07429487 still recruiting?

NCT07429487 is currently not yet recruiting. Last updated 24 February 2026.

Last reviewed 2026-02-24 · How we verify

NCT07429487: WATCH AND ACT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Not yet recruiting NA Last updated 24 February 2026

What this trial tests

NA trial testing APA program in Breast Cancer in 98 participants. Not yet recruiting.

Timeline

15 June 2026

Primary endpoint
15 September 2029

15 June 2030

Quick facts

Lead sponsor	Centre Antoine Lacassagne
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	98
Start date	15 June 2026
Primary completion	15 September 2029
Estimated completion	15 June 2030
Sites	1 location across France

Drugs / interventions tested

APA program

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Colorectal Cancer — all drugs for Colorectal Cancer →
Ovarian Adenocarcinoma — all drugs for Ovarian Adenocarcinoma →
Pancreatic Cancer — all drugs for Pancreatic Cancer →

Sponsor

Centre Antoine Lacassagne — full company profile →

Who can join

Adults 18 to 75, any sex, with Breast Cancer or Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A single-center, randomized (1:1) open-label, prospective, stratified study with two parallel arms, designed to evaluate adherence to the adapted physical activity (APA) program for patients participating in an APA program and to compare changes in fatigue at 3 months in patients who have completed adjuvant systemic chemotherapy for cancer and are participating in an APA program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of APA program

Trials testing the same drug.

NCT02184663 — Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer · NA · unknown

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Centre Antoine Lacassagne trials

Trials by the same sponsor.

NCT06782451 — Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity · NA · recruiting
NCT06606366 — Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplina · NA · recruiting
NCT06400849 — Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy · NA · recruiting
NCT06029218 — Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy · NA · recruiting
NCT06058312 — Individual Food Preferences for the Mediterranean Diet in Cancer Patients · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07429487 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Antoine Lacassagne
Last refreshed: 24 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07429487.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing